Clinical Trial Update: Pharmacogenomics of GLP1 Receptor Agonists [Phase 1]

View source ↗

Summary

A Phase 1 pharmacogenomics study evaluating responses to GLP-1 receptor agonists in type 2 diabetes mellitus was terminated, with results posted on 2025-07-01.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonists (class)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED | Results posted: 2025-07-01